Cells of the multidrug efflux pumps, which use proteins to rid themselves of toxic substances, appear essential to how this drug-resistant organism develops.
Understanding multidrug resistance in Staphylococcus aureus: The role of efflux pumps and key protein structures
Mohammad Abuzar, Foorkan Fakki
- Editor approved · 16 Nov 2026
- December 2024
- DOI 10.56511/jipbs.2024.11403
The question
What part do efflux pumps play in the resistance of Staphylococcus aureus to many drugs?
- Illness caused by bacteria resistant to many drugs, whether caught in healthcare buildings or in public places, is a growing concern for health.
- Biofilms and efflux pumps are named as the main causes of antibiotic resistance in this organism.
What was done
- The article reviews what is understood today about the multidrug efflux pump and why it matters in the clinic.
- It concentrates on recent discoveries about the efflux system of this organism, and on how the pumps are regulated through the expression of proteins and genes.
- Significant genes and proteins are set out, each with its PDB identifier.
Key findings
The efflux pump NorA of this organism, which belongs to the primary facilitator superfamily, imparts resistance to a variety of substrates.
Many efflux pump inhibitors have been found, yet none has reached clinical approval, because of unfavourable toxicity.
Recent research is cited to the effect that cells may put the efflux systems to use as a first step of defence, keeping drugs below deadly concentrations while a stabler and more effective change is awaited.
Why it matters
- Efflux systems matter in resistance to many drugs and also carry molecules needed for signalling between cells; because they are so common, the authors warn of a real danger of returning to a time before antibiotics.
- No inhibitor of these pumps is yet approved for use in the clinic, which the authors put down to unfavourable toxicity.
How to cite
Mohammad Abuzar, Foorkan Fakki. Understanding multidrug resistance in Staphylococcus aureus: The role of efflux pumps and key protein structures. Journal of Innovations in Pharmaceutical and Biological Sciences. 2024;11(04):22-35. https://doi.org/10.56511/jipbs.2024.11403
- The article at doi.org (the publisher's page and PDF)
- The article on the journal's site
- The journal at the ISSN Portal (ISSN 2349-2759)